Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Antitumor efficacy of paclitaxel-loaded polylactide/ poly(ethylene glycol) nanoparticles combination with exercise in tumor-bearing mice.

Zhang J, Ma Z, Liu P, Ji Q, Qi J, Duan Y.

J Nanosci Nanotechnol. 2013 Jun;13(6):3868-73.

PMID:
23862420
2.

Cytotoxicity of Paclitaxel in biodegradable self-assembled core-shell poly(lactide-co-glycolide ethylene oxide fumarate) nanoparticles.

He X, Ma J, Mercado AE, Xu W, Jabbari E.

Pharm Res. 2008 Jul;25(7):1552-62. doi: 10.1007/s11095-007-9513-z. Epub 2008 Jan 15.

PMID:
18196205
3.

Folate-decorated hybrid polymeric nanoparticles for chemically and physically combined paclitaxel loading and targeted delivery.

Wang J, Liu W, Tu Q, Wang J, Song N, Zhang Y, Nie N, Wang J.

Biomacromolecules. 2011 Jan 10;12(1):228-34. doi: 10.1021/bm101206g. Epub 2010 Dec 15.

PMID:
21158381
4.

Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.

Zhan C, Gu B, Xie C, Li J, Liu Y, Lu W.

J Control Release. 2010 Apr 2;143(1):136-42. doi: 10.1016/j.jconrel.2009.12.020. Epub 2010 Jan 7.

PMID:
20056123
5.

Preparation and in vitro properties of redox-responsive polymeric nanoparticles for paclitaxel delivery.

Song N, Liu W, Tu Q, Liu R, Zhang Y, Wang J.

Colloids Surf B Biointerfaces. 2011 Oct 15;87(2):454-63. doi: 10.1016/j.colsurfb.2011.06.009. Epub 2011 Jun 15.

PMID:
21719259
6.

Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.

Lu J, Chuan X, Zhang H, Dai W, Wang X, Wang X, Zhang Q.

Int J Pharm. 2014 Aug 25;471(1-2):525-35. doi: 10.1016/j.ijpharm.2014.05.032. Epub 2014 May 22.

PMID:
24858391
7.
8.

Nanoparticles of star-like copolymer mannitol-functionalized poly(lactide)-vitamin E TPGS for delivery of paclitaxel to prostate cancer cells.

Wang K, Guo L, Xiong W, Sun L, Zheng Y.

J Biomater Appl. 2014 Sep;29(3):329-40. doi: 10.1177/0885328214527486. Epub 2014 Mar 12.

PMID:
24621530
9.

Deoxycholic acid-modified chitooligosaccharide/mPEG-PDLLA mixed micelles loaded with paclitaxel for enhanced antitumor efficacy.

Jiang C, Wang H, Zhang X, Sun Z, Wang F, Cheng J, Xie H, Yu B, Zhou L.

Int J Pharm. 2014 Nov 20;475(1-2):60-8. doi: 10.1016/j.ijpharm.2014.08.037. Epub 2014 Aug 23.

PMID:
25152167
10.
11.

Effects of poly(ethylene glycol) grafting density on the tumor targeting efficacy of nanoparticles with ligand modification.

Zhang S, Tang C, Yin C.

Drug Deliv. 2015 Feb;22(2):182-90. doi: 10.3109/10717544.2013.854849. Epub 2013 Nov 12.

PMID:
24215373
12.

Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(ɛ-caprolactone) nanoparticles: In vitro and in vivo evaluation.

Xin H, Chen L, Gu J, Ren X, Wei Z, Luo J, Chen Y, Jiang X, Sha X, Fang X.

Int J Pharm. 2010 Dec 15;402(1-2):238-47. doi: 10.1016/j.ijpharm.2010.10.005. Epub 2010 Oct 8.

PMID:
20934500
13.

Novel biodegradable polylactide/poly(ethylene glycol) micelles prepared by direct dissolution method for controlled delivery of anticancer drugs.

Yang L, Wu X, Liu F, Duan Y, Li S.

Pharm Res. 2009 Oct;26(10):2332-42. doi: 10.1007/s11095-009-9949-4. Epub 2009 Aug 8.

PMID:
19669098
14.

Effect of polyethylene glycol (PEG) chain organization on the physicochemical properties of poly(D, L-lactide) (PLA) based nanoparticles.

Essa S, Rabanel JM, Hildgen P.

Eur J Pharm Biopharm. 2010 Jun;75(2):96-106. doi: 10.1016/j.ejpb.2010.03.002. Epub 2010 Mar 6.

PMID:
20211727
15.

Improved antifungal activity of itraconazole-loaded PEG/PLA nanoparticles.

Essa S, Louhichi F, Raymond M, Hildgen P.

J Microencapsul. 2013;30(3):205-17. doi: 10.3109/02652048.2012.714410. Epub 2012 Aug 15.

PMID:
22894166
16.

Preparation and antitumor characteristics of PLA/(PEG-PPG-PEG) nanoparticles loaded with camptothecin.

Kunii R, Onishi H, Machida Y.

Eur J Pharm Biopharm. 2007 Aug;67(1):9-17. Epub 2007 Jan 28.

PMID:
17337172
17.

Tumor-targeted paclitaxel-loaded folate conjugated poly(ethylene glycol)-poly(L-lactide) microparticles produced by supercritical fluid technology.

Huang X, Zhang Y, Yin G, Pu X, Liao X, Huang Z, Chen X, Yao Y.

J Mater Sci Mater Med. 2015 Feb;26(2):95. doi: 10.1007/s10856-015-5447-x. Epub 2015 Feb 4.

PMID:
25649516
18.

Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density.

Essa S, Rabanel JM, Hildgen P.

Int J Pharm. 2011 Jun 15;411(1-2):178-87. doi: 10.1016/j.ijpharm.2011.02.039. Epub 2011 Mar 31.

PMID:
21458551
19.

Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles.

Wang H, Zhao Y, Wu Y, Hu YL, Nan K, Nie G, Chen H.

Biomaterials. 2011 Nov;32(32):8281-90. doi: 10.1016/j.biomaterials.2011.07.032. Epub 2011 Jul 31.

PMID:
21807411
20.

Co-delivery of TRAIL gene enhances the anti-glioblastoma effect of paclitaxel in vitro and in vivo.

Zhan C, Wei X, Qian J, Feng L, Zhu J, Lu W.

J Control Release. 2012 Jun 28;160(3):630-6. doi: 10.1016/j.jconrel.2012.02.022. Epub 2012 Mar 3.

PMID:
22410115

Supplemental Content

Support Center